MILWAUKEE, Feb. 27, 2013 (GLOBE NEWSWIRE) -- We are investigating possible securities fraud claims against Accretive Health, Inc. (AH) resulting from inaccurate statements the Company made from February 20, 2012 to February 26, 2013 regarding its financial performance and future prospects.
Click here to learn how to learn more about the investigation: http://www.ademilaw.com/case/accretive-health-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
On February 26, 2013, Accretive announced that it would postpone the release of its financial results for the fourth quarter and full year 2012 because it was evaluating the timing of revenue recognition for its revenue cycle management agreements. Such evaluation might lead to restatements of Accretive's financial statements, rendering its previously filed financial statements false and misleading.
If you purchased stock between February 20, 2012 to February 26, 2013 and wish to obtain additional information, please contact Guri Ademi either at firstname.lastname@example.org or toll-free: 866-264-3995, http://www.ademilaw.com/case/accretive-health-inc.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Ademi & O'Reilly, LLP Guri Ademi 3620 East Layton Ave. Cudahy, WI 53110 Toll Free: (866) 264-3995 Fax: (414) 482-8001 www.ademilaw.comSource:Ademi & O'Reilly, LLP